Publicacións nas que colabora con MARIA JOAO CORREIA PINTO CARVALHO DE MATOS (28)

2023

  1. 8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies

    European Journal of Medicinal Chemistry, Vol. 248

2022

  1. Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin

    Molecules, Vol. 27, Núm. 3

  2. Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives

    ChemMedChem, Vol. 17, Núm. 21

2021

  1. 7-Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation

    ChemMedChem, Vol. 16, Núm. 1, pp. 179-186

  2. Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors

    Bioorganic Chemistry, Vol. 108

2020

  1. 3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter?

    Bioorganic Chemistry, Vol. 101

  2. Coumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents

    ChemMedChem, Vol. 15, Núm. 6, pp. 532-538

  3. Discovery and optimization of 3-thiophenylcoumarins as novel agents against Parkinson's disease: Synthesis, in vitro and in vivo studies

    Bioorganic Chemistry, Vol. 101

2019

  1. Design, Synthesis and Docking Calculations of Prenylated Chalcones as Selective Monoamine Oxidase B Inhibitors with Antioxidant Activity

    ChemistrySelect, Vol. 4, Núm. 26, pp. 7698-7703

2018

  1. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. MAO inhibitory activity of bromo-2-phenylbenzofurans: Synthesis,: in vitro study, and docking calculations

    MedChemComm, Vol. 8, Núm. 9, pp. 1788-1796

2015

  1. 3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases

    ChemMedChem, Vol. 10, Núm. 12, pp. 2071-2079

  2. Potent and selective MAO-B inhibitory activity: Amino- versus nitro-3-arylcoumarin derivatives

    Bioorganic and Medicinal Chemistry Letters, Vol. 25, Núm. 3, pp. 642-648

2014

  1. Insight into the functional and structural properties of 3-arylcoumarin as an interesting scaffold in monoamine oxidase B inhibition

    ChemMedChem, Vol. 9, Núm. 7, pp. 1488-1500

  2. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases

    Future Medicinal Chemistry, Vol. 6, Núm. 4, pp. 371-383

2013

  1. MAO Inhibitory Activity of 2-Arylbenzofurans versus 3-Arylcoumarins: Synthesis, invitro Study, and Docking Calculations

    ChemMedChem, Vol. 8, Núm. 6, pp. 956-966

  2. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study

    European Journal of Medicinal Chemistry, Vol. 63, pp. 151-161

2012

  1. 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease

    MedChemComm, Vol. 3, Núm. 2, pp. 213-218

  2. 8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies

    ChemMedChem, Vol. 7, Núm. 3, pp. 464-470

  3. Focusing on new monoamine oxidase inhibitors: Differently substituted coumarins as an interesting scaffold

    Current Topics in Medicinal Chemistry, Vol. 12, Núm. 20, pp. 2210-2239